AAAAAA
Results:
1-23
|
Results: 23
Authors:
Stefanadis, C
Manolis, A
Dernellis, J
Tsioufis, C
Tsiamis, E
Gavras, I
Gavras, H
Toutouzas, P
Citation: C. Stefanadis et al., Acute effect of clonidine on left ventricular pressure-volume relation in hypertensive patients with diastolic heart dysfunction, J HUM HYPER, 15(9), 2001, pp. 635-642
Authors:
Gavras, I
Gavras, H
Citation: I. Gavras et H. Gavras, Role of alpha(2)-adrenergic receptors in hypertension, AM J HYPERT, 14(6), 2001, pp. 171S-177S
Authors:
Kintsurashvili, E
Duka, I
Gavras, I
Johns, C
Farmakiotis, D
Gavras, H
Citation: E. Kintsurashvili et al., Effects of ANG II on bradykinin receptor gene expression in cardiomyocytesand vascular smooth muscle cells, AM J P-HEAR, 281(4), 2001, pp. H1778-H1783
Authors:
Gavras, I
Manolis, AJ
Gavras, H
Citation: I. Gavras et al., The alpha(2)-adrenergic receptors in hypertension and heart failure: experimental and clinical studies, J HYPERTENS, 19(12), 2001, pp. 2115-2124
Authors:
Kintsurashvili, E
Gavras, I
Johns, C
Gavras, H
Citation: E. Kintsurashvili et al., Effects of antisense oligodeoxynucleotide targeting of the alpha(2B)-adrenergic receptor messenger RNA in the central nervous system, HYPERTENSIO, 38(5), 2001, pp. 1075-1080
Authors:
Gavras, I
Citation: I. Gavras, Is ancient Greek a dead language?, LANCET, 358(9279), 2001, pp. 424-424
Authors:
DeStefano, AL
Gavras, H
Heard-Costa, N
Bursztyn, M
Manolis, A
Farrer, LA
Baldwin, CT
Gavras, I
Schwartz, F
Citation: Al. Destefano et al., Maternal component in the familial aggregation of hypertension, CLIN GENET, 60(1), 2001, pp. 13-21
Authors:
Duka, I
Kintsurashvili, E
Gavras, I
Johns, C
Bresnahan, M
Gavras, H
Citation: I. Duka et al., Vasoactive potential of the B-1 bradykinin receptor in normotension and hypertension, CIRCUL RES, 88(3), 2001, pp. 275-281
Authors:
Gavras, I
Gavras, H
Citation: I. Gavras et H. Gavras, Angiotensin-converting enzyme inhibitors, CUR CL PRAC, 2001, pp. 315-324
Authors:
Gavras, I
Gavras, H
Citation: I. Gavras et H. Gavras, The antiarrhythmic potential of angiotensin II antagonism: Experience withlosartan, AM J HYPERT, 13(5), 2000, pp. 512-517
Authors:
Duka, I
Gavras, I
Johns, C
Handy, DE
Gavras, H
Citation: I. Duka et al., Role of the postsynaptic alpha(2)-adrenergic receptor subtypes in catecholamine-induced vasoconstriction, GEN PH-VASC, 34(2), 2000, pp. 101-106
Authors:
Nicolaou, M
DeStefano, AL
Gavras, I
Cupples, LA
Manolis, AJ
Baldwin, CT
Gavras, H
Farrer, LA
Citation: M. Nicolaou et al., Genetic predisposition to stroke in relatives of hypertensives, STROKE, 31(2), 2000, pp. 487-492
Authors:
Gavras, H
Gavras, I
Citation: H. Gavras et I. Gavras, Commentary: Implications for the pathophysiology of hypertension and heartfailure derived from clinical experience with drugs modifying the renin-angiotensin system, V CH MO CAR, 1, 2000, pp. 187-190
Authors:
Gavras, I
Manolis, A
Gavras, H
Citation: I. Gavras et al., Genetic epidemiology of essential hypertension, J HUM HYPER, 13(4), 1999, pp. 225-229
Authors:
Baldwin, CT
Schwartz, F
Baima, J
Burzstyn, H
DeStefano, AL
Gavras, I
Handy, DE
Joost, O
Martel, T
Manolis, A
Nicolaou, M
Bresnahan, M
Farrer, L
Gavras, H
Citation: Ct. Baldwin et al., Identification of a polymorphic glutamic acid stretch in the alpha(2B)-adrenergic receptor and lack of linkage with essential hypertension, AM J HYPERT, 12(9), 1999, pp. 853-857
Authors:
Manolis, AJ
Tsalopoulos, E
Ramos, C
Katsaros, K
Dalabiras, P
Hatzissavas, J
Foussas, S
Gavras, I
Bresnahan, M
Gavras, H
Citation: Aj. Manolis et al., Benefits of central sympathetic suppression with clonidine after acute myocardial infarction, ADV THER, 16(6), 1999, pp. 272-282
Authors:
Gavras, I
Gavras, H
Citation: I. Gavras et H. Gavras, Effects of eprosartan versus enalapril in hypertensive patients on the renin-angiotensin-aldosterone system and safety parameters: Results from a 26-week, double-blind, multicentre study, CURR MED R, 15(1), 1999, pp. 15-24
Authors:
Gavras, I
Gavras, H
Citation: I. Gavras et H. Gavras, Safety and tolerability of eprosartan, PHARMACOTHE, 19(4), 1999, pp. 102S-107S
Authors:
Makaritsis, KP
Johns, C
Gavras, I
Altman, JD
Handy, DE
Bresnahan, MR
Gavras, H
Citation: Kp. Makaritsis et al., Sympathoinhibitory function of the alpha(2A)-adrenergic receptor subtype, HYPERTENSIO, 34(3), 1999, pp. 403-407
Authors:
Baima, J
Nicolaou, M
Schwartz, F
DeStefano, AL
Manolis, A
Gavras, I
Laffer, C
Elijovich, F
Farrer, L
Baldwin, CT
Gavras, H
Citation: J. Baima et al., Evidence for linkage between essential hypertension and a putative locus on human chromosome 17, HYPERTENSIO, 34(1), 1999, pp. 4-7
Authors:
Makaritsis, KP
Handy, DE
Johns, C
Kobilka, B
Gavras, I
Gavras, H
Citation: Kp. Makaritsis et al., Role of the alpha(2B)-adrenergic receptor in the development of salt-induced hypertension, HYPERTENSIO, 33(1), 1999, pp. 14-17
Authors:
Gavras, I
Manolis, AJ
Gavras, H
Citation: I. Gavras et al., The economics of therapeutic advances - The paradigm of sympathetic suppression in chronic heart failure, ARCH IN MED, 159(22), 1999, pp. 2634-2636
Authors:
Gavras, H
Gavras, I
Citation: H. Gavras et I. Gavras, The renin-angiotensin system and the heart, CONT ENDOC, 21, 1999, pp. 53-67
Risultati:
1-23
|